loader image

Don’t Wait for a Pullback. Start Playing Defense Now

by | Nov 4, 2021 | Stocks

What’s happening in the Nasdaq right now is amazing… 

But the contrarian in me can’t help but wonder how long the market can keep this up, and it’s actually time to start considering my top defensive stocks for November 2021 (more on those later).  

Once that hot earnings season air leaks out — and it will — those nasty headlines from September that were pushed off the front page are ready to jump back in the spotlight. 

That means more focus on shipping bottlenecks, Washington gridlock and Chinese regulatory and real estate dysfunction. 

And even though I’m still bullish on retail and the holiday season — just look at that earnings beat from our good friend Under Armour (NYSE: UAA) — I’m less optimistic that the holidays will hold Mr. Market’s attention. 

If those negative headlines creep back in the media, then another 4% or 5% correction isn’t out of the question… 

Which is why I’m ready to move on a few of my top defensive stocks for November 2021… 

6 Top Defensive Stocks for November 2021

The stocks I’m talking about here go by a lot of different names… 

Some traders call them defensive, low-beta or flight-to-safety stocks… And others might just call them plain boring, because these stocks typically aren’t wild movers on their own. But they’re  my top defensive stocks for November 2021!

When markets stop making sense or start to crack, traders look to companies in food and beverage like Keurig Dr Pepper Inc. (Nasdaq: KDP), grocers like Albertsons Companies Inc. (NYSE: ACI), household products like Procter & Gamble Co. (NYSE: PG) or even tobacco names like Altria Group Inc. (NYSE: MO)

That stability limits risk to the downside, though, it can also limit the upside… 

But it doesn’t mean top defensive stocks for November 2021 can’t move… It’s more that they won’t make BIG moves without news or a big event — like November’s earnings. 

Just look at the move of our boring old friend Pfizer Inc. (NYSE: PFE) made on Tuesday… 

A 4% bounce may sound boring, but the smart money was ready and waiting for takeoff. 

The Blitz Tracker picked up a big buy in the Pfizer Nov. 5 $43.50 strike calls on Oct. 27. That day, the calls traded for $0.69 at the close… Four days before, those options hit $2.50 on earnings! 

And traders watching the tracker spot that institutional trade LIVE in the Daily Profits Challenge War Room had all the information they needed to get another winning trade off the ground! 

Check out the short video and let’s talk about these screwy markets and look at some of my top defensive stocks for November 2021. 

P.S. Aggressive “desk clearing” FDA approvals have fuelled at least some of the latest profits of 2021… And the next 61 days could be even bigger.

Researchers from Harvard and MIT noted in a recent report that “approval spikes occur at the end of each calendar month,” and before the “end of the year in a kind of ‘desk-clearing’ activity.”

So dozens of stocks are set to pop in the next 61 days as the FDA plans to clear its backlog of drug approvals. 

Click Here to Find Out More! 

WRITTEN BY<br>Lance Ippolito

WRITTEN BY
Lance Ippolito

What to read next

99 Problems and a “Pivot” is One

99 Problems and a “Pivot” is One

A friend of mine sent me this chart about three months ago. I should probably print it and keep it in my wallet next to a photo of my daughter. Given the sheer number of questions I’ve fielded lately, I’ll probably end up showing this chart more than her picture.

read more
Everything Everywhere, Going Down, All At Once

Everything Everywhere, Going Down, All At Once

When our momentum reading went negative last week, I didn’t know that we’d have the second largest bank failure in U.S. history three days later. All I knew was that it went negative… and that we got out of the way.

read more
Trust But Verify…

Trust But Verify…

I want to talk about our version of “Trust but Verify” in the markets. Qualification is the most important part of the investing process. And this F score value strategy looks to be crushing the current market.

read more

Have any questions? Contact Our Customer Service Team